Barbara E Bierer

Barbara Emily Bierer, MD

Professor of Medicine (Pediatrics), HMS
Member, HMS Center for Bioethics

Barbara Bierer, MD is a Professor of Medicine (Pediatrics) at Harvard Medical School (HMS), and a hematologist/oncologist at the Brigham and Women's Hospital (BWH). She received her MD from HMS. She is the director of the Regulatory Foundations, Law and Ethics Program of the Harvard Catalyst, the Harvard Clinical and Translational Science Award, and the director of regulatory policy, SMART IRB. Dr. Bierer co-founded and now leads the Multi-Regional Clinical Trials Center of BWH and Harvard (MRCT Center), a University-wide and collaborative effort to improve the ethics, conduct, and regulatory environment for multi-site, multi-national clinical trials. She is a co-founder of COVID-19 Collaboration Platform, a platform for cooperation in research. In 2017, the MRCT Center launched the non-profit Vivli, a global clinical research data sharing platform. From 2003-2014, she served as Senior Vice President, Research, at BWH and was the institutional official for human subjects and animal research, for biosafety and for research integrity at the BWH. She initiated the Brigham Research Institute and the Innovation Hub (iHub), a focus for entrepreneurship and innovation. Dr. Bierer established and directed the Center for Faculty Development and Diversity at the BWH; for these efforts, she was the first recipient of the HMS Harold Amos Faculty Diversity Award.

Publications View
The APC-associated protein EB1 associates with components of the dynactin complex and cytoplasmic dynein intermediate chain.
Authors: Authors: Berrueta L, Tirnauer JS, Schuyler SC, Pellman D, Bierer BE.
Curr Biol
View full abstract on Pubmed
Actin stabilization by jasplakinolide enhances apoptosis induced by cytokine deprivation.
Authors: Authors: Posey SC, Bierer BE.
J Biol Chem
View full abstract on Pubmed
CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28.
Authors: Authors: Slavik JM, Hutchcroft JE, Bierer BE.
J Biol Chem
View full abstract on Pubmed
CD28/CTLA-4 and CD80/CD86 families: signaling and function.
Authors: Authors: Slavik JM, Hutchcroft JE, Bierer BE.
Immunol Res
View full abstract on Pubmed
Uncoupling activation-dependent HS1 phosphorylation from nuclear factor of activated T cells transcriptional activation in Jurkat T cells: differential signaling through CD3 and the costimulatory receptors CD2 and CD28.
Authors: Authors: Hutchcroft JE, Slavik JM, Lin H, Watanabe T, Bierer BE.
J Immunol
View full abstract on Pubmed
The adenomatous polyposis coli-binding protein EB1 is associated with cytoplasmic and spindle microtubules.
Authors: Authors: Berrueta L, Kraeft SK, Tirnauer JS, Schuyler SC, Chen LB, Hill DE, Pellman D, Bierer BE.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
Identification of a proline-rich sequence in the CD2 cytoplasmic domain critical for regulation of integrin-mediated adhesion and activation of phosphoinositide 3-kinase.
Authors: Authors: Kivens WJ, Hunt SW, Mobley JL, Zell T, Dell CL, Bierer BE, Shimizu Y.
Mol Cell Biol
View full abstract on Pubmed
Association of p59(fyn) with the T lymphocyte costimulatory receptor CD2. Binding of the Fyn Src homology (SH) 3 domain is regulated by the Fyn SH2 domain.
Authors: Authors: Lin H, Hutchcroft JE, Andoniou CE, Kamoun M, Band H, Bierer BE.
J Biol Chem
View full abstract on Pubmed
Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines.
Authors: Authors: Dunussi-Joannopoulos K, Dranoff G, Weinstein HJ, Ferrara JL, Bierer BE, Croop JM.
Blood
View full abstract on Pubmed
Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia.
Authors: Authors: Ballen KK, Gilliland DG, Guinan EC, Hsieh CC, Parsons SK, Rimm IJ, Ferrara JL, Bierer BE, Weinstein HJ, Antin JH.
Bone Marrow Transplant
View full abstract on Pubmed